{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:20:46Z","timestamp":1780093246347,"version":"3.54.0"},"reference-count":61,"publisher":"American Society for Microbiology","issue":"17","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU EI"],"award-info":[{"award-number":["TTU EI"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["166265"],"award-info":[{"award-number":["166265"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>Despite the availability of vaccines, annual influenza virus epidemics cause 250,000 to 500,000 deaths worldwide. Currently licensed inactivated vaccines, which are standardized for the amount of the hemagglutinin (HA) antigen, primarily induce strain-specific antibodies, whereas the immune response to the neuraminidase (NA) antigen, which is also present on the viral surface, is usually low. Using NA-expressing single-cycle vesicular stomatitis virus replicons, we show that the NA antigen conferred protection of mice and ferrets against not only the matched influenza virus strains but also viruses carrying NA proteins from other strains of the same subtype. The extent of protection correlated with the level of cross-reactive NA-inhibiting antibodies. This highlights the potential of the NA antigen for the development of more broadly protective influenza vaccines. Such vaccines may also provide partial protection against newly emerging strains with the same NA but a different HA subtype.<\/jats:p>","DOI":"10.1128\/jvi.01006-18","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T09:39:44Z","timestamp":1529055584000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":52,"title":["Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype"],"prefix":"10.1128","volume":"92","author":[{"given":"Lisa","family":"Walz","sequence":"first","affiliation":[{"name":"Veterinary Medicine Division, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Katharina","family":"Kays","sequence":"additional","affiliation":[{"name":"Veterinary Medicine Division, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany"},{"name":"German Centre for Infection Research (DZIF), TTU Emerging Infections, Langen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2708-2507","authenticated-orcid":false,"given":"Gert","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Institute of Virology and Immunology, Mittelh\u00e4usern, Switzerland"},{"name":"Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3972-8723","authenticated-orcid":false,"given":"Veronika","family":"von Messling","sequence":"additional","affiliation":[{"name":"Veterinary Medicine Division, Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany"},{"name":"German Centre for Infection Research (DZIF), TTU Emerging Infections, Langen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"318","article-title":"Nosocomial influenza A (H1N1) infection","volume":"46","author":"Balkovic ES","year":"1980","unstructured":"Balkovic ES, Goodman RA, Rose FB, Borel CO. 1980. Nosocomial influenza A (H1N1) infection. Am J Med Technol 46:318\u2013320.","journal-title":"Am J Med Technol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.10.908"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00003-0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00040503"},{"key":"e_1_3_2_6_2","first-page":"20","article-title":"Antigenic variation in influenza viruses","volume":"8","author":"Air GM","year":"1987","unstructured":"Air GM, Laver WG, Webster RG. 1987. Antigenic variation in influenza viruses. Contrib Microbiol Immunol 8:20\u201359.","journal-title":"Contrib Microbiol Immunol"},{"key":"e_1_3_2_7_2","first-page":"1647","volume-title":"Fields virology","author":"Palese P","year":"2007","unstructured":"Palese P, Shaw ML. 2007. Orthomyxoviridae: the viruses and their replication, p 1647\u20131689. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.","edition":"5"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178258"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-92165-3_12"},{"key":"e_1_3_2_10_2","volume-title":"WHO technical report series, 2005","author":"Dobbelaer R","year":"2005","unstructured":"Dobbelaer R, Levandowsky R, Wood JA. 2005. WHO technical report series, 2005. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.05.036"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02556-14"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/v6062465"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02949-14"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-017-0011-8"},{"key":"e_1_3_2_16_2","first-page":"2010","article-title":"Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience","volume":"139","author":"Johansson BE","year":"1987","unstructured":"Johansson BE, Moran TM, Bona CA, Popple SW, Kilbourne ED. 1987. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience. Virus Res 139:2010\u20132014.","journal-title":"Virus Res"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7114"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02275-15"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.10.001"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.3.1239-1246.1989"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/129.4.411"},{"key":"e_1_3_2_22_2","first-page":"647","article-title":"The role of antineuraminidase antibody in immunity to influenza virus infection","volume":"41","author":"Schulman JL","year":"1969","unstructured":"Schulman JL. 1969. The role of antineuraminidase antibody in immunity to influenza virus infection. Bull World Health Organ 41:647\u2013650.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-22-1-35"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00149-3"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/657084"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02434-12"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.6.4704-4711.1998"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414216"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv082"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1214441110"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.5604\/17322693.1083016"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.03.002"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.12.019"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066059"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.087"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab3920"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1309977"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.065201-0"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.2.8.778-786.1968"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.011"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2015.03.017"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178258"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nsb0298-119"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1713"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.21.13231-13238.2005"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159237"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2011.09.022"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.5.3723-3732.1999"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.030"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.06.006"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2007.10.002"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00279-X"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00585-15"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026335"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv195"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000049"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01203-13"},{"key":"e_1_3_2_58_2","volume-title":"WHO manual on animal influenza diagnosis and surveillance","author":"WHO","year":"2002","unstructured":"WHO. 2002. WHO manual on animal influenza diagnosis and surveillance. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00843-X"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025858"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1177\/104063870201400215"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2014.09.003"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01006-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01006-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T14:40:46Z","timestamp":1646491246000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01006-18"}},"subtitle":[],"editor":[{"given":"Stacey","family":"Schultz-Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":61,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1128\/JVI.01006-18"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01006-18","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"2018-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01006-18"}}